JP2024517789A5 - - Google Patents
Info
- Publication number
- JP2024517789A5 JP2024517789A5 JP2023567067A JP2023567067A JP2024517789A5 JP 2024517789 A5 JP2024517789 A5 JP 2024517789A5 JP 2023567067 A JP2023567067 A JP 2023567067A JP 2023567067 A JP2023567067 A JP 2023567067A JP 2024517789 A5 JP2024517789 A5 JP 2024517789A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- pharmaceutically acceptable
- acceptable salt
- unsubstituted
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182734P | 2021-04-30 | 2021-04-30 | |
| US63/182,734 | 2021-04-30 | ||
| PCT/US2022/026676 WO2022232360A1 (en) | 2021-04-30 | 2022-04-28 | Small molecule modulators of glucocerebrosidase activity and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517789A JP2024517789A (ja) | 2024-04-23 |
| JP2024517789A5 true JP2024517789A5 (https=) | 2025-05-08 |
Family
ID=83848814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567067A Pending JP2024517789A (ja) | 2021-04-30 | 2022-04-28 | グルコセレブロシダーゼ活性の小分子モジュレータ及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240246952A1 (https=) |
| EP (1) | EP4329880A4 (https=) |
| JP (1) | JP2024517789A (https=) |
| KR (1) | KR20240016286A (https=) |
| CN (1) | CN117751114A (https=) |
| AU (1) | AU2022267285A1 (https=) |
| BR (1) | BR112023022567A2 (https=) |
| CA (1) | CA3218510A1 (https=) |
| MX (1) | MX2023012853A (https=) |
| WO (1) | WO2022232360A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025237303A1 (zh) * | 2024-05-14 | 2025-11-20 | 先声药业有限公司 | β-葡萄糖脑苷脂酶变构调节剂、其药物组合物及用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0325956D0 (en) * | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| US7488721B2 (en) * | 2004-05-13 | 2009-02-10 | Mcmaster University | Real time methylumbelliferone-based assay |
| AU2009303441A1 (en) * | 2008-10-16 | 2010-04-22 | Schering Corporation | Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| US8354403B2 (en) * | 2009-08-27 | 2013-01-15 | Merck Sharp & Dohme Corp. | Pyrrolidine derived beta 3 adrenergic receptor agonists |
| KR101880411B1 (ko) * | 2009-10-19 | 2018-07-19 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 중추신경계의 퇴행성 질환을 예방 및/또는 치료하는 신규 조성물 |
| HK1220325A1 (zh) * | 2013-03-15 | 2017-05-05 | Whitehead Institute For Biomedical Research | 苯并咪唑衍生物及其用途 |
| US9796680B2 (en) * | 2013-12-23 | 2017-10-24 | Alectos Therapeutics Inc. | Glucocerebrosidase modulators and uses thereof |
| CN108290855A (zh) * | 2015-07-01 | 2018-07-17 | 西北大学 | 被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途 |
| WO2019027765A1 (en) * | 2017-08-02 | 2019-02-07 | Northwestern University | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS AND USES THEREOF |
| EP4039685A1 (en) * | 2021-02-08 | 2022-08-10 | Irbm S.P.A. | Azabicyclic shp2 inhibitors |
-
2022
- 2022-04-28 MX MX2023012853A patent/MX2023012853A/es unknown
- 2022-04-28 CA CA3218510A patent/CA3218510A1/en active Pending
- 2022-04-28 WO PCT/US2022/026676 patent/WO2022232360A1/en not_active Ceased
- 2022-04-28 US US18/288,933 patent/US20240246952A1/en active Pending
- 2022-04-28 EP EP22796703.1A patent/EP4329880A4/en active Pending
- 2022-04-28 JP JP2023567067A patent/JP2024517789A/ja active Pending
- 2022-04-28 AU AU2022267285A patent/AU2022267285A1/en active Pending
- 2022-04-28 CN CN202280046279.XA patent/CN117751114A/zh active Pending
- 2022-04-28 BR BR112023022567A patent/BR112023022567A2/pt unknown
- 2022-04-28 KR KR1020237041444A patent/KR20240016286A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7326622B2 (ja) | Ｅｒｋ阻害剤としてのスピロ系化合物およびその使用 | |
| JP2021534124A5 (https=) | ||
| JP2020183410A5 (https=) | ||
| JP2011509309A5 (https=) | ||
| JP2007508361A5 (https=) | ||
| JP2006504658A5 (https=) | ||
| JP2019505541A5 (https=) | ||
| JP2005508349A5 (https=) | ||
| JP2014516360A5 (https=) | ||
| JP2018518537A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2014506907A5 (https=) | ||
| JP2008195730A5 (https=) | ||
| JP2008513498A5 (https=) | ||
| JP2011057693A5 (https=) | ||
| JP2014503574A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JP2014507455A5 (https=) | ||
| CA2679198A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| JP2007519649A5 (https=) | ||
| JP2008509187A5 (https=) | ||
| JP2014511892A5 (https=) | ||
| JP2020517707A5 (https=) | ||
| JP2011517697A5 (https=) | ||
| RU2007146669A (ru) | Пролекарства антагонистов a2b рецептора аденозина |